	Four Gene Polymorphisms as Potential Predictive Biomarkers for Lung Cancer Susceptibility and Therapeutic Response in Iraqi Patients: A Pharmacogenetic Case-Control Study. Asian Pac J Cancer Prev Orabiy MO, Chyad DH, Hoidy WH. PMID: 41660933 [PubMed - indexed for MEDLINE]
	Knowledge, Attitudes, and Screening Practices for Lung Cancer in Uzbekistan: A Nationwide Cross-Sectional Study. Asian Pac J Cancer Prev Dadaboev A, Shukurova M, Aziziy A, Ruziyeva N, Shakib Kotamjani S. PMID: 41660911 [PubMed - indexed for MEDLINE]
	"I had to figure this out for myself." Patients and healthcare professionals' perspectives on rehabilitation uptake after treatment for head, neck and lung cancer: a qualitative interview study. Disabil Rehabil Jelstrup Balkin E, Andreasen J, Petersen KS, Navntoft S, Jørgensen L. PMID: 41660865 [PubMed - as supplied by publisher]
	Effects of Kang'ai injection combined with chemotherapy on immune function in advanced non-small cell lung cancer: a meta-analysis. Front Pharmacol Wang Y, Wang X, Zhang H, Zhao X, Zhang T, Wang X, Wang Y. PMID: 41660512 [PubMed]
	The evolving role of neoadjuvant immunotherapy in resectable non-small cell lung cancer: a narrative review. J Thorac Dis Yao Z, Sun B, Zhang M, Ge P. PMID: 41660484 [PubMed]
	Prevalence and predictors of frailty among older patients with lung cancer: a systematic review and meta-analysis. J Thorac Dis Liu L, Zhang F, Sun X, Cui J, Li J, Sun J. PMID: 41660476 [PubMed]
	Radiotherapy combined with third-generation EGFR tyrosine kinase inhibitor in first-line treatment of advanced oligometastatic non-small cell lung cancer: a single-center, retrospective study. J Thorac Dis Chen J, Yao J, Cheng Q, Wang Y, Wei Z, Chen H, Wang L, Wang R, Ma H, Lin X, Xu Y. PMID: 41660475 [PubMed]
	The efficacy and predictive factors of first-line immune checkpoint inhibitors for advanced non-small cell lung cancer with driver or non-driver gene alterations: a retrospective cohort study. J Thorac Dis He Q, Guo XB, Chen YR, Gao XX, Zhao J, Zhong W, Chen MJ, Xu Y, Wang MZ. PMID: 41660470 [PubMed]
	Efficacy and safety of time-of-day infusion of pemetrexed plus platinum for patients with advanced non-small cell lung cancer: a retrospective cohort study. J Thorac Dis Hao MD, Xie P, Xu QA, Li JJ, Xian KX, Xu X, Liu WL, Zhou DY, Wang ZY, Zeng XX, Zhang XH. PMID: 41660457 [PubMed]
	Is the consolidation-to-tumor ratio an independent prognostic factor in clinical T1 stage lung adenocarcinoma radiologically manifesting as a subsolid nodule?-a retrospective cohort study. J Thorac Dis Zhang X, Wang D, Fu P, Xu P, Wu L, Qiu H, Fu T, Zhang Y, Zhang G. PMID: 41660455 [PubMed]
	Nonlinear association between advanced lung cancer inflammation index and latent tuberculosis infection risk: threshold effects and predictive value of a novel biomarker. J Thorac Dis Yong Y, Zhou LH, Ran XQ, Yang SY, Chen YY. PMID: 41660449 [PubMed]
	Flumonertinib after prior third-generation EGFR-tyrosine kinase inhibitor (TKI) therapy in patients with epidermal growth factor receptor-mutated non-small cell lung cancer after resistance to third-generation tyrosine kinase inhibitor treatment: a real-world study. J Thorac Dis Wang H, Zhang C, Du S, Wang H. PMID: 41660441 [PubMed]
	Machine learning-driven PET-CT and clinical pathology model for predicting mediastinal lymph node metastasis in non-small cell lung cancer: a retrospective cohort study. PeerJ Bi T, Qiang M, Duan X, Yin Y, Zhang W, Chen Z, Zhang X, Ma J, Zhang B, Tang M, Liu W. PMID: 41660073 [PubMed - indexed for MEDLINE]
	Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans. PeerJ Shao K, Du F, Qiu L, Zhang Y, Li Y, Ding J, Zhan W, Chen W. PMID: 41660071 [PubMed - indexed for MEDLINE]
	Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis. Front Immunol Jia J, Zeng Y, Ji Y, Zhu H, Meng R, Xia B, Wang Y, Shen T, Su X, Zhou T, Lu Y, Zhao L, Yang Z, Fu X, Cai X. PMID: 41659851 [PubMed - indexed for MEDLINE]
	Brain metastases from non-small cell lung cancer: molecular subtypes and emerging CNS-directed precision therapies. Front Oncol Sharma M, Shah A, Rivera-Caraballo KA, Raval G, Kaur B, Wallace GC 4th. PMID: 41659723 [PubMed]
	Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer combined with moderate-to-severe pulmonary dysfunction. Front Oncol Chen Y, Du C, Li C, Meng H, Kong F. PMID: 41659722 [PubMed]
	Metabolic reprogramming and lung cancer focused on roles, mechanism, and clinical prospects of circRNAs: a narrative review. Front Oncol Chen S, Li M, Li S, Sun Y, Wang L. PMID: 41659720 [PubMed]
	Utility of various programmed death-ligand 1 (PD-L1) assays in predicting the clinical benefit of immune checkpoint inhibitors in PD-L1-expressing non-small-cell lung cancer patients: a systematic review. Transl Lung Cancer Res Soo RA, Lim DW, Yang JC, Shih JY, Herbst RS. PMID: 41659274 [PubMed]
	Clinicopathological characteristics associated with intrapulmonary metastasis rather than single primary lung cancer at first diagnosis: a study based on the Surveillance, Epidemiology, and End Results database using Bayesian networks and structural equation modeling. Transl Lung Cancer Res Liu W, Chan JCS, Chang ATC, Chan JWY, Lau RWH, Mok TSK, Ng CSH. PMID: 41659273 [PubMed]

Articles 1 - 20 / 156213

Page 1 of 7811



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy